BNT163b2 immunogenicity in patients with PIMS-TS/MIS-C history

This dataset includes the data for a prospective cohort study evaluating of Pfizer-BioNTech COVID-19 mRNA bnt163b2 vaccine (Comirnaty®) immunogenicity reactogenicity among patients with the anamnesis of paediatric inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) and among healthy controls without such an anamnesis. The ethical approval was obtained from the Bioethics Committee at Wroclaw Medical University (CWN UMW BW: 313/2020 and CWN UMW BW 42/2022)